- Home
- AZTR vs IPDN Comparison
AZTR vs IPDN Comparison
Compare AZTR & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTR
- IPDN
- Stock Information
- Founded
- AZTR 2014
- IPDN 2003
- Country
- AZTR United States
- IPDN United States
- Employees
- AZTR N/A
- IPDN N/A
- Industry
- AZTR Biotechnology: Pharmaceutical Preparations
- IPDN EDP Services
- Sector
- AZTR Health Care
- IPDN Technology
- Exchange
- AZTR Nasdaq
- IPDN Nasdaq
- Market Cap
- AZTR 3.7M
- IPDN 5.2M
- IPO Year
- AZTR 2023
- IPDN 2013
- Fundamental
- Price
- AZTR $0.94
- IPDN $2.14
- Analyst Decision
- AZTR
- IPDN
- Analyst Count
- AZTR 0
- IPDN 0
- Target Price
- AZTR N/A
- IPDN N/A
- AVG Volume (30 Days)
- AZTR 1.5M
- IPDN 1.8M
- Earning Date
- AZTR 08-11-2025
- IPDN 08-14-2025
- Dividend Yield
- AZTR N/A
- IPDN N/A
- EPS Growth
- AZTR N/A
- IPDN N/A
- EPS
- AZTR N/A
- IPDN N/A
- Revenue
- AZTR N/A
- IPDN $6,459,379.00
- Revenue This Year
- AZTR N/A
- IPDN N/A
- Revenue Next Year
- AZTR N/A
- IPDN N/A
- P/E Ratio
- AZTR N/A
- IPDN N/A
- Revenue Growth
- AZTR N/A
- IPDN N/A
- 52 Week Low
- AZTR $0.81
- IPDN $0.97
- 52 Week High
- AZTR $5.06
- IPDN $11.20
- Technical
- Relative Strength Index (RSI)
- AZTR 31.60
- IPDN 47.98
- Support Level
- AZTR $0.81
- IPDN $2.03
- Resistance Level
- AZTR $1.07
- IPDN $2.20
- Average True Range (ATR)
- AZTR 0.11
- IPDN 0.19
- MACD
- AZTR 0.00
- IPDN -0.01
- Stochastic Oscillator
- AZTR 22.02
- IPDN 44.33
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.